Navigating barriers to sexual rehabilitation for women with spinal cord injuries– an Indian perspective
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - 2028
Project Lead
Authors
Dr. Anindya Debnath, Dr. Jaya Das, Dr. Babna Joseph, Dr. Aneeta Shaji, Dr NC Chandini
Project Status
ongoing
Project Type
Descriptive study